<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Moxonidine and hydrochlorothiazide in combination : a synergistic antihypertensive effect</dc:title>
  <dc:creator>FREI, M</dc:creator>
  <dc:creator>KÜSTER, L</dc:creator>
  <dc:creator>GARDOSCH VON KROSIGK, P.-P</dc:creator>
  <dc:creator>KOCH, H.-F</dc:creator>
  <dc:creator>KÜPPERS, H</dc:creator>
  <dc:contributor>PAPP, J. Gy (Editor)</dc:contributor>
  <dc:contributor>OLLIVIER, J.-P (Editor)</dc:contributor>
  <dc:contributor>European Society of Cardiology (Funder/Sponsor)</dc:contributor>
  <dc:contributor>I1-Imidazoline-receptor agonists : a new concept in hypertension. Satellite symposium (Nice 1993-09-01)</dc:contributor>
  <dc:relation>Journal of cardiovascular pharmacology -- J. cardiovasc. pharmacol, CODEN JCPCDT, ISSN 0160-2446, Vol. 24, pp. S25-S28</dc:relation>
  <dc:relation>I1-Imidazoline-receptor agonists : a new concept in hypertension. Satellite symposium</dc:relation>
  <dc:date>1994</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Conference Paper</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Lippincott</dc:publisher>
  <dc:publisher>Lippincott</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>8 ref</dc:format>
  <dc:subject xml:lang="fr">Agoniste</dc:subject>
  <dc:subject xml:lang="fr">Antihypertenseur</dc:subject>
  <dc:subject xml:lang="fr">Association médicamenteuse</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Diurétique</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Hydrochlorothiazide</dc:subject>
  <dc:subject xml:lang="fr">Hypertension artérielle</dc:subject>
  <dc:subject xml:lang="fr">Moxonidine</dc:subject>
  <dc:subject xml:lang="fr">Thiazide</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Récepteur imidazoline I1</dc:subject>
  <dc:subject xml:lang="fr">Récepteur imidazoline</dc:subject>
  <dc:subject xml:lang="en">Agonist</dc:subject>
  <dc:subject xml:lang="en">Antihypertensive agent</dc:subject>
  <dc:subject xml:lang="en">Drug combination</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Diuretic</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Hypertension</dc:subject>
  <dc:subject xml:lang="en">Thiazide</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Imidazoline recepteur</dc:subject>
  <dc:subject xml:lang="es">Agonista</dc:subject>
  <dc:subject xml:lang="es">Antihipertensivo</dc:subject>
  <dc:subject xml:lang="es">Asociación medicamentosa</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Diurético</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Hipertensión arterial</dc:subject>
  <dc:subject xml:lang="es">Tiazida</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02F05: Antihypertenseurs / Antihypertensive agents</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 3372868</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>